Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Card Message Is Reaching Seniors, CMS’ McClellan Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Administrator McClellan says call volume to the Medicare toll-free number was up 133% for the week following launch of drug discount card website. CMS is providing $21.1 mil. to state health insurance and assistance programs to publicize drug card program.

You may also be interested in...



Medicare Rx Card "Therapeutic Alternatives" Website Feature Will Be Available "Soon"

The price comparison feature may be launched "as soon as" the week of June 7, Administrator McClellan says. CMS is releasing study results showing savings on generics available under Medicare discount cards one day before a Senate Finance Committee hearing.

Medicare Rx Card "Therapeutic Alternatives" Website Feature Will Be Available "Soon"

The price comparison feature may be launched "as soon as" the week of June 7, Administrator McClellan says. CMS is releasing study results showing savings on generics available under Medicare discount cards one day before a Senate Finance Committee hearing.

Medicare Rx Discount Program Includes Five Cards Offered Free Of Charge

HHS expects 48 cards will be offered to the general Medicare population, with 27 available nationally. Scrip Solutions and WellPoint are offering national cards with no enrollment fee.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel